Sign in
4

Changes in Ownership

XBiotech Inc. Filed Acc 0001209191-18-063616

Chief Executive Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
SIMARD JOHN Chief Executive Officer 2018-12-19 Option exercise +50,000 $2.50 $125,000 6,327,060 D
Derivatives
SIMARD JOHN Chief Executive Officer 2018-12-19 Option exercise · Stock Option −50,000 0 D
Loading xslF345X03/doc4.xml…